Lidocaine 5% Patch (Lidoderm) for the Prevention of Acute and Chest Pain Following Robotic Valve Surgery

NACompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

September 30, 2009

Primary Completion Date

April 30, 2011

Study Completion Date

April 30, 2011

Conditions
Perioperative Chest Pain
Interventions
DRUG

Lidoderm 5 % Topical Patch

Patients will receive Lidoderm topical 5% lidocaine patches. Those will be placed to affected area up to three patches as needed for pain 12 hours on and 12 hours off

DRUG

Placebo patch

2\) Group II: Patients will receive placebo patches. Those will be placed to affected area at dose up to three patches as needed for pain 12 hours on and 12 hours off

Trial Locations (1)

44195

Cleveland Clinic, Cleveland

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Endo Pharmaceuticals

INDUSTRY

lead

The Cleveland Clinic

OTHER